Effects of N-acetylcysteine in endotoxic shock

J Crit Care. 1994 Dec;9(4):236-43. doi: 10.1016/0883-9441(94)90003-5.

Abstract

Purpose: The release of oxygen-free radicals has been implicated in both peripheral vascular and myocardial alterations of septic shock. N-Acetylcysteine (N-AC), a substrate for the production of glutathione, has potent antioxidant effects. As a nitrosothiol, it may also improve capillary blood flow. We studied the effects of N-AC in a dog model of endotoxic shock.

Methods: Ten pentobarbital-anesthetized, mechanically ventilated dogs were randomly assigned to receive either N-AC (150 mg/kg loading dose in 1 hour, followed by 20 mg/kg.h maintenance dose) or D5W. After the loading dose, each dog received 3 mg/kg Escherichia coli endotoxin intravenously. After 30 minutes, saline infusion was started to restore and maintain baseline filling pressures.

Results: The loading dose of N-AC increased DO2 significantly (from 661 +/- 54 to 914 +/- 190 mL/min, P < .05), but VO2 remained stable. After the administration of endotoxin, fluid challenge restored cardiac output to baseline, in both groups. Hemoglobin and, thus, DO2 were slightly lower in the N-AC-treated dogs, but VO2 was similar in both groups. At the end of the study, O2ER was significantly higher in the N-AC-treated dogs than in the control dogs. Blood lactate levels fell more rapidly in the N-AC dogs than in the control dogs. Blood lactate levels returned to normal in the N-AC dogs but not in the control dogs. Tumor necrosis factor (TNF) also decreased significantly in the N-AC dogs but remained elevated in the control dogs.

Conclusion: These data indicate that N-AC administration in endotoxic shock is well tolerated, may increase oxygen availability to the tissues, and is associated with an attenuation of TNF release.

MeSH terms

  • Acetylcysteine / blood
  • Acetylcysteine / therapeutic use*
  • Analysis of Variance
  • Animals
  • Blood Pressure / drug effects
  • Cardiac Output / drug effects
  • Disease Models, Animal
  • Dogs
  • Lactates / blood
  • Random Allocation
  • Respiratory Function Tests
  • Shock, Septic / drug therapy*
  • Shock, Septic / metabolism
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / metabolism
  • Vasodilator Agents / blood
  • Vasodilator Agents / therapeutic use*

Substances

  • Lactates
  • Tumor Necrosis Factor-alpha
  • Vasodilator Agents
  • Acetylcysteine